Shen Gao Selected Research

MicroRNAs (MicroRNA)

1/2020	Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.
9/2019	Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy.
1/2016	Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy.
1/2014	Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo.
1/2011	Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shen Gao Research Topics

Disease

40	Neoplasms (Cancer) 05/2024 - 06/2005
25	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 05/2004
10	Breast Neoplasms (Breast Cancer) 04/2023 - 06/2005
5	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2020
5	Stomach Neoplasms (Stomach Cancer) 03/2023 - 01/2019
5	Carcinogenesis 01/2020 - 01/2019
4	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2013
3	Triple Negative Breast Neoplasms 01/2024 - 09/2019
3	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2023 - 01/2023
3	Atherosclerosis 10/2018 - 06/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 01/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2024 - 01/2021
2	Inflammation (Inflammations) 04/2023 - 01/2019
2	Acidosis 04/2023 - 11/2022
2	Glioma (Gliomas) 01/2022 - 02/2007
2	Carcinoma (Carcinomatosis) 01/2022 - 07/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 10/2018 - 08/2018
2	Fatigue 01/2017 - 11/2008
2	Lung Neoplasms (Lung Cancer) 11/2016 - 09/2012
2	Melanoma (Melanoma, Malignant) 08/2016 - 01/2011
2	Leukemia 06/2007 - 04/2006
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2024
1	Eclampsia 01/2024
1	Pre-Eclampsia (Preeclampsia) 01/2024
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2024
1	Choroidal Neovascularization 01/2024
1	Macular Degeneration (Age-Related Maculopathy) 01/2024
1	Hyperthermia 11/2023
1	Hypothyroidism 08/2023
1	Hypoxia (Hypoxemia) 04/2023
1	Congenital Abnormalities (Deformity) 01/2023

Drug/Important Bio-Agent (IBA)

12	Peptides (Polypeptides)IBA 01/2022 - 01/2012
11	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 06/2005
10	MicellesIBA 08/2022 - 01/2016
8	AndrogensIBA 01/2022 - 07/2005
7	Androgen Receptors (Androgen Receptor)IBA 04/2024 - 05/2004
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2005
7	Small Interfering RNA (siRNA)IBA 12/2022 - 06/2005
6	Docetaxel (Taxotere)FDA Link 01/2021 - 10/2016
5	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2011
5	LigandsIBA 10/2019 - 01/2011
4	enzalutamideIBA 04/2024 - 01/2021
4	oxidized low density lipoproteinIBA 01/2024 - 06/2017
4	RNA (Ribonucleic Acid)IBA 11/2022 - 04/2015
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
3	Nanoparticle Drug Delivery SystemIBA 01/2022 - 09/2018
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	CateninsIBA 01/2020 - 01/2019
3	DisulfidesIBA 01/2019 - 09/2016
3	Arginine (L-Arginine)FDA Link 01/2018 - 01/2012
2	AntibodiesIBA 05/2024 - 10/2018
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2024 - 08/2023
2	Liposomes (Liposome)IBA 01/2024 - 04/2023
2	Malondialdehyde (Propanedial)IBA 01/2023 - 11/2008
2	IronIBA 01/2023 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2023
2	Superoxide DismutaseIBA 01/2023 - 11/2008
2	EnzymesIBA 01/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 02/2021
2	OligodeoxyribonucleotidesIBA 01/2022 - 09/2018
2	Long Noncoding RNAIBA 07/2021 - 01/2019
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 02/2021 - 02/2007
2	CytokinesIBA 01/2019 - 01/2005
2	PPAR deltaIBA 01/2019 - 01/2019
2	Carbon Nanotubes (Carbon Nanotube)IBA 09/2018 - 01/2018
2	Monoclonal AntibodiesIBA 08/2018 - 01/2011
2	Aspartic Acid (Aspartate)FDA Link 01/2018 - 01/2012
2	PolyethyleneimineIBA 01/2018 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2018
2	ChitosanIBA 01/2018 - 01/2017
2	Thioctic Acid (Lipoic Acid)IBA 11/2016 - 09/2016
2	APTIBA 10/2016 - 01/2014
2	Dacarbazine (DIC)FDA LinkGeneric 08/2016 - 01/2011
2	SuspensionsIBA 11/2009 - 04/2006
1	Axitinib (AG 013736)IBA 05/2024
1	T140 peptideIBA 04/2024
1	CarbonIBA 01/2024
1	KH902 fusion proteinIBA 01/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024
1	penetratinIBA 01/2024
1	Hyaluronic Acid (Hyaluronan)IBA 01/2024
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2024
1	Ophthalmic Solutions (Eye Drops)IBA 01/2024
1	AdiponectinIBA 12/2023
1	iron carbideIBA 11/2023
1	AcidsIBA 11/2023
1	NanocapsulesIBA 11/2023
1	Iodide Peroxidase (Deiodinase)IBA 08/2023
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 08/2023
1	Uric Acid (Urate)IBA 06/2023
1	TabletsIBA 03/2023
1	Capecitabine (Xeloda)FDA Link 03/2023

Therapy/Procedure

22	Therapeutics 01/2024 - 01/2011
10	Drug Therapy (Chemotherapy) 01/2024 - 06/2006
8	Immunotherapy 01/2024 - 01/2011
7	Castration 04/2024 - 06/2006
4	Lasers (Laser) 01/2024 - 12/2010
2	Precision Medicine 11/2023 - 11/2022
1	Intravitreal Injections 01/2024